ID: ALA4064564

Max Phase: Preclinical

Molecular Formula: C11H11ClO3

Molecular Weight: 226.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)c1cccc(CC(=O)O)c1Cl

Standard InChI:  InChI=1S/C11H11ClO3/c1-2-9(13)8-5-3-4-7(11(8)12)6-10(14)15/h3-5H,2,6H2,1H3,(H,14,15)

Standard InChI Key:  VYNWQRJLEFFYJW-UHFFFAOYSA-N

Associated Targets(Human)

Interleukin-8 receptors, CXCR1/CXCR2 285 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 226.66Molecular Weight (Monoisotopic): 226.0397AlogP: 2.56#Rotatable Bonds: 4
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.73CX Basic pKa: CX LogP: 2.47CX LogD: -0.82
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.80Np Likeness Score: -0.33

References

1. Liu YM, Nepali K, Liou JP..  (2017)  Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets.,  60  (2): [PMID:28122457] [10.1021/acs.jmedchem.6b00935]

Source